 const medicinesample=[
    {
      name: "Letrozole",
      description: "Letrozole is an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the production of estrogen, thereby slowing down or stopping the growth of cancer cells.",
      price: 1200,
      life_span: "2026-06-30"
    },
    {
      name: "Tamoxifen",
      description: "Tamoxifen is a selective estrogen receptor modulator (SERM) used to treat both early and advanced hormone receptor-positive breast cancer. It blocks the effects of estrogen in the breast tissue, preventing the growth of cancer cells.",
      price: 1500,
      life_span: "2025-12-31"
    },
    {
      name: "Trastuzumab",
      description: "Trastuzumab is a monoclonal antibody used to treat HER2-positive breast cancer. It works by targeting the HER2 protein, which is overexpressed in some breast cancers, and inhibiting its activity, thereby slowing or stopping the growth of cancer cells.",
      price: 2000,
      life_span: "2025-10-15"
    },
    {
      name: "Anastrozole",
      description: "Anastrozole is an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the production of estrogen, which can help slow or stop the growth of cancer cells.",
      price: 1300,
      life_span: "2025-11-30"
    },
    {
      name: "Exemestane",
      description: "Exemestane is an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the production of estrogen in the body.",
      price: 1800,
      life_span: "2026-04-15"
    },
    {
      name: "Palbociclib",
      description: "Palbociclib is a targeted therapy used in combination with hormone therapy to treat hormone receptor-positive, HER2-negative advanced breast cancer. It works by inhibiting cyclin-dependent kinases, which are involved in cell cycle progression.",
      price: 2200,
      life_span: "2025-09-20"
    },
    {
      name: "Fulvestrant",
      description: "Fulvestrant is a hormone therapy used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by blocking the action of estrogen and reducing the growth of cancer cells.",
      price: 1700,
      life_span: "2026-01-10"
    },
    {
      name: "Ribociclib",
      description: "Ribociclib is a targeted therapy used in combination with hormone therapy to treat hormone receptor-positive, HER2-negative advanced breast cancer. It works by inhibiting cyclin-dependent kinases, which are involved in cell cycle progression.",
      price: 2100,
      life_span: "2025-08-25"
    },
    {
      name: "Everolimus",
      description: "Everolimus is a targeted therapy used in combination with hormone therapy to treat hormone receptor-positive, HER2-negative advanced breast cancer. It works by inhibiting a protein called mTOR, which is involved in cell growth and division.",
      price: 1900,
      life_span: "2025-07-12"
    },
    {
      name: "Capecitabine",
      description: "Capecitabine is a chemotherapy drug used to treat breast cancer that has spread to other parts of the body. It is converted into 5-fluorouracil in the body, which interferes with the growth of cancer cells.",
      price: 1600,
      life_span: "2025-03-28"
    },
    {
      name: "Eribulin",
      description: "Eribulin is a chemotherapy drug used to treat metastatic breast cancer. It works by inhibiting the growth of cancer cells and disrupting the microtubule network within the cells.",
      price: 2300,
      life_span: "2025-05-20"
    },
    {
      name: "Ibrance",
      description: "Ibrance is a targeted therapy used in combination with hormone therapy to treat hormone receptor-positive, HER2-negative advanced breast cancer. It works by inhibiting cyclin-dependent kinases, which are involved in cell cycle progression.",
      price: 2400,
      life_span: "2025-11-05"
    },
    {
      name: "Neratinib",
      description: "Neratinib is a targeted therapy used to treat early-stage HER2-positive breast cancer. It works by blocking multiple pathways involved in the growth and survival of cancer cells.",
      price: 2000,
      life_span: "2025-06-15"
    },
    {
      name: "Pertuzumab",
      description: "Pertuzumab is a monoclonal antibody used in combination with other drugs to treat HER2-positive breast cancer. It works by binding to the HER2 receptor and inhibiting its ability to signal for cell growth.",
      price: 2100,
      life_span: "2026-03-10"
    },
    {
      name: "Ado-Trastuzumab Emtansine",
      description: "Ado-Trastuzumab Emtansine is a targeted therapy used to treat HER2-positive metastatic breast cancer. It combines the HER2-targeted antibody trastuzumab with a chemotherapy drug, emtansine, to deliver the chemotherapy directly to cancer cells.",
      price: 2500,
      life_span: "2026-02-18"
    }
  ];
  module.exports={data:medicinesample};
  